"
Team:Waterloo
From 2014.igem.org
(Difference between revisions)
| Line 9: | Line 9: | ||
#contentSub, #footer-box, #catlinks, #search-controls, #p-logo, .printfooter, .firstHeading,.visualClear {display: none;} /*-- hides default wiki settings --*/ | #contentSub, #footer-box, #catlinks, #search-controls, #p-logo, .printfooter, .firstHeading,.visualClear {display: none;} /*-- hides default wiki settings --*/ | ||
</style> | </style> | ||
| - | <div style="position: relative; top: -30px; margin: 0px - | + | <div style="position: relative; top: -30px; margin: 0px -5px;"> |
<div class="blueOnGrey"> | <div class="blueOnGrey"> | ||
<h1>Staphylocide</h1> | <h1>Staphylocide</h1> | ||
Revision as of 22:30, 17 October 2014
Staphylocide
Delivering Antibiotic Resistance Gene Silencing Mechanism to a MRSA Population using Bacterial Conjugation
Problem
MRSA is sweeping the nation, an antibiotic-resistant scourge migrating from hospitals into communities. We need a hero to fight it and Waterloo iGEM has designed a synthetic bacterium that just might do the trick...
Solution
...Staphylocide! Staphylocide delivers antibiotic resistance gene silencing in vivo and could one day be incorporated into a treatment that would help doctors defeat MRSA once and for all.
Project Cornerstones
Explore the three cornerstones of this year's project: delivering the silencing in vivo using conjugation, silencing mecA expression using CRISPRi and sRNA and translating from the lab to the patients.
